1. Home
  2. LBTYK vs GH Comparison

LBTYK vs GH Comparison

Compare LBTYK & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LBTYK
  • GH
  • Stock Information
  • Founded
  • LBTYK 2004
  • GH 2011
  • Country
  • LBTYK Bermuda
  • GH United States
  • Employees
  • LBTYK N/A
  • GH N/A
  • Industry
  • LBTYK Cable & Other Pay Television Services
  • GH Medical Specialities
  • Sector
  • LBTYK Telecommunications
  • GH Health Care
  • Exchange
  • LBTYK Nasdaq
  • GH Nasdaq
  • Market Cap
  • LBTYK 4.3B
  • GH 4.7B
  • IPO Year
  • LBTYK N/A
  • GH 2018
  • Fundamental
  • Price
  • LBTYK $12.00
  • GH $48.31
  • Analyst Decision
  • LBTYK
  • GH Strong Buy
  • Analyst Count
  • LBTYK 0
  • GH 14
  • Target Price
  • LBTYK N/A
  • GH $39.93
  • AVG Volume (30 Days)
  • LBTYK 1.5M
  • GH 1.9M
  • Earning Date
  • LBTYK 01-01-0001
  • GH 02-20-2025
  • Dividend Yield
  • LBTYK N/A
  • GH N/A
  • EPS Growth
  • LBTYK N/A
  • GH N/A
  • EPS
  • LBTYK N/A
  • GH N/A
  • Revenue
  • LBTYK $7,674,500,000.00
  • GH $692,256,000.00
  • Revenue This Year
  • LBTYK $2.89
  • GH $32.21
  • Revenue Next Year
  • LBTYK N/A
  • GH $16.90
  • P/E Ratio
  • LBTYK N/A
  • GH N/A
  • Revenue Growth
  • LBTYK 3.53
  • GH 29.20
  • 52 Week Low
  • LBTYK $11.25
  • GH $15.81
  • 52 Week High
  • LBTYK $22.14
  • GH $45.66
  • Technical
  • Relative Strength Index (RSI)
  • LBTYK 27.67
  • GH 80.22
  • Support Level
  • LBTYK $11.90
  • GH $36.45
  • Resistance Level
  • LBTYK $12.30
  • GH $39.29
  • Average True Range (ATR)
  • LBTYK 0.33
  • GH 2.36
  • MACD
  • LBTYK 0.02
  • GH 1.00
  • Stochastic Oscillator
  • LBTYK 2.01
  • GH 96.41

About LBTYK Liberty Global Ltd. Class C

Liberty Global is a holding company with interests in several telecom companies in the UK, Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty is the owner of the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile-network-operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: